^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Yuanruida (inaticabtagene autoleucel)

i
Associations
Company:
CASI, Juventas Cell Therapy
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations